321 related articles for article (PubMed ID: 26775768)
1. Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency.
; Smith RC; Smith SF; Wilson J; Pearce C; Wray N; Vo R; Chen J; Ooi CY; Oliver M; Katz T; Turner R; Nikfarjam M; Rayner C; Horowitz M; Holtmann G; Talley N; Windsor J; Pirola R; Neale R
Pancreatology; 2016; 16(2):164-80. PubMed ID: 26775768
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and management of pancreatic exocrine insufficiency.
Nikfarjam M; Wilson JS; Smith RC;
Med J Aust; 2017 Aug; 207(4):161-165. PubMed ID: 28814218
[TBL] [Abstract][Full Text] [Related]
3. Clinical, anthropometric and laboratory nutritional markers of pancreatic exocrine insufficiency: Prevalence and diagnostic use.
Lindkvist B; Phillips ME; Domínguez-Muñoz JE
Pancreatology; 2015; 15(6):589-97. PubMed ID: 26243045
[TBL] [Abstract][Full Text] [Related]
4. Pancrelipase: an evidence-based review of its use for treating pancreatic exocrine insufficiency.
Nakajima K; Oshida H; Muneyuki T; Kakei M
Core Evid; 2012; 7():77-91. PubMed ID: 22936895
[TBL] [Abstract][Full Text] [Related]
5. Pancrelipase for pancreatic disorders: An update.
Dhanasekaran R; Toskes PP
Drugs Today (Barc); 2010 Nov; 46(11):855-66. PubMed ID: 21225024
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of pancreatic exocrine replacement therapy for patients with unresectable pancreatic cancer in a randomized trial.
Woo SM; Joo J; Kim SY; Park SJ; Han SS; Kim TH; Koh YH; Chung SH; Kim YH; Moon H; Hong EK; Lee WJ
Pancreatology; 2016; 16(6):1099-1105. PubMed ID: 27618657
[TBL] [Abstract][Full Text] [Related]
7. Maldigestion from pancreatic exocrine insufficiency.
Pongprasobchai S
J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():99-102. PubMed ID: 24251713
[TBL] [Abstract][Full Text] [Related]
8. Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis.
Domínguez-Muñoz JE; Nieto-Garcia L; López-Díaz J; Lariño-Noia J; Abdulkader I; Iglesias-Garcia J
BMC Cancer; 2018 May; 18(1):534. PubMed ID: 29728096
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of pancreatin minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis.
Morawski JH; Prüfert A; van Engen A; Foerster D; Sander-Struckmeier S; Małecka-Panas E; Pezzilli R
J Med Econ; 2012; 15 Suppl 1():15-25. PubMed ID: 23043594
[TBL] [Abstract][Full Text] [Related]
10. Exocrine pancreatic insufficiency following esophagectomy.
Huddy JR; Macharg FM; Lawn AM; Preston SR
Dis Esophagus; 2013 Aug; 26(6):594-7. PubMed ID: 23199208
[TBL] [Abstract][Full Text] [Related]
11. Contribution of pancreatic enzyme replacement therapy to survival and quality of life in patients with pancreatic exocrine insufficiency.
Layer P; Kashirskaya N; Gubergrits N
World J Gastroenterol; 2019 May; 25(20):2430-2441. PubMed ID: 31171887
[TBL] [Abstract][Full Text] [Related]
12. Enzyme replacement improves survival among patients with pancreatic cancer: Results of a population based study.
Roberts KJ; Bannister CA; Schrem H
Pancreatology; 2019 Jan; 19(1):114-121. PubMed ID: 30385188
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management of pancreatic exocrine insufficiency (PEI) in primary care: consensus guidance of a Canadian expert panel.
Durie P; Baillargeon JD; Bouchard S; Donnellan F; Zepeda-Gomez S; Teshima C
Curr Med Res Opin; 2018 Jan; 34(1):25-33. PubMed ID: 28985688
[TBL] [Abstract][Full Text] [Related]
14. Expert opinion on management of pancreatic exocrine insufficiency in pancreatic cancer.
Roeyen G; Berrevoet F; Borbath I; Geboes K; Peeters M; Topal B; Van Cutsem E; Van Laethem JL
ESMO Open; 2022 Feb; 7(1):100386. PubMed ID: 35124465
[TBL] [Abstract][Full Text] [Related]
15. Exocrine Pancreatic Insufficiency Dosing Guidelines for Pancreatic Enzyme Replacement Therapy Vary Widely Across Disease Types.
Lewis DM; Rieke JG; Almusaylim K; Kanchibhatla A; Blanchette JE; Lewis C
Dig Dis Sci; 2024 Feb; 69(2):615-633. PubMed ID: 38117426
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment of pancreatic exocrine insufficiency.
Dominguez-Muñoz JE
Curr Opin Gastroenterol; 2018 Sep; 34(5):349-354. PubMed ID: 29889111
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic Exocrine Insufficiency as a Complication of Gastrointestinal Surgery and the Impact of Pancreatic Enzyme Replacement Therapy.
Chaudhary A; Domínguez-Muñoz JE; Layer P; Lerch MM
Dig Dis; 2020; 38(1):53-68. PubMed ID: 31422398
[TBL] [Abstract][Full Text] [Related]
18. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency.
Kuhn RJ; Gelrud A; Munck A; Caras S
Adv Ther; 2010 Dec; 27(12):895-916. PubMed ID: 21086085
[TBL] [Abstract][Full Text] [Related]
19. The use of pancreatic enzyme replacement therapy in patients with a diagnosis of chronic pancreatitis and pancreatic cancer in the US is infrequent and inconsistent.
Forsmark CE; Tang G; Xu H; Tuft M; Hughes SJ; Yadav D
Aliment Pharmacol Ther; 2020 May; 51(10):958-967. PubMed ID: 32249970
[TBL] [Abstract][Full Text] [Related]
20. A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery.
Gubergrits N; Malecka-Panas E; Lehman GA; Vasileva G; Shen Y; Sander-Struckmeier S; Caras S; Whitcomb DC
Aliment Pharmacol Ther; 2011 May; 33(10):1152-61. PubMed ID: 21418260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
